- call +1-201-465-4211
- email sales@mrinsights.biz
Medications for movement disorders. Drugs to treat movement disorders include the following: Tetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.
Scope of the Report:
This report studies the Huntington’s Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Huntington’s Disease Treatment market by product type and applications/end industries.
Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipeline, rise in target population, and favorable government initiatives are some of the key factors contributing to market growth.
The global Huntington’s Disease Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Huntington’s Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Valeant Pharmaceuticals
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Symptomatic Therapy
Disease-Modifying Therapy
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Huntington’s Disease Treatment Market Overview
1.1 Product Overview and Scope of Huntington’s Disease Treatment
1.2 Classification of Huntington’s Disease Treatment by Types
1.2.1 Global Huntington’s Disease Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Huntington’s Disease Treatment Revenue Market Share by Types in 2017
1.2.3 Symptomatic Therapy
1.2.4 Disease-Modifying Therapy
1.3 Global Huntington’s Disease Treatment Market by Application
1.3.1 Global Huntington’s Disease Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Global Huntington’s Disease Treatment Market by Regions
1.4.1 Global Huntington’s Disease Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Huntington’s Disease Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Huntington’s Disease Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Huntington’s Disease Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Huntington’s Disease Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Huntington’s Disease Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Huntington’s Disease Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Valeant Pharmaceuticals
2.1.1 Business Overview
2.1.2 Huntington’s Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Valeant Pharmaceuticals Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva Pharmaceuticals
2.2.1 Business Overview
2.2.2 Huntington’s Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Pharmaceuticals Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Wave Life Sciences
2.3.1 Business Overview
2.3.2 Huntington’s Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Wave Life Sciences Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ionis Pharmaceuticals/ Roche
2.4.1 Business Overview
2.4.2 Huntington’s Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Raptor Pharmaceuticals
2.5.1 Business Overview
2.5.2 Huntington’s Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Raptor Pharmaceuticals Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Prana Biotechnology
2.6.1 Business Overview
2.6.2 Huntington’s Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Prana Biotechnology Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Huntington’s Disease Treatment Market Competition, by Players
3.1 Global Huntington’s Disease Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Huntington’s Disease Treatment Players Market Share
3.2.2 Top 10 Huntington’s Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Huntington’s Disease Treatment Market Size by Regions
4.1 Global Huntington’s Disease Treatment Revenue and Market Share by Regions
4.2 North America Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
5 North America Huntington’s Disease Treatment Revenue by Countries
5.1 North America Huntington’s Disease Treatment Revenue by Countries (2013-2018)
5.2 USA Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
6 Europe Huntington’s Disease Treatment Revenue by Countries
6.1 Europe Huntington’s Disease Treatment Revenue by Countries (2013-2018)
6.2 Germany Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
6.4 France Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Huntington’s Disease Treatment Revenue by Countries
7.1 Asia-Pacific Huntington’s Disease Treatment Revenue by Countries (2013-2018)
7.2 China Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
7.5 India Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
8 South America Huntington’s Disease Treatment Revenue by Countries
8.1 South America Huntington’s Disease Treatment Revenue by Countries (2013-2018)
8.2 Brazil Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Huntington’s Disease Treatment by Countries
9.1 Middle East and Africa Huntington’s Disease Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Huntington’s Disease Treatment Revenue and Growth Rate (2013-2018)
10 Global Huntington’s Disease Treatment Market Segment by Type
10.1 Global Huntington’s Disease Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Huntington’s Disease Treatment Market Forecast by Type (2018-2023)
10.3 Symptomatic Therapy Revenue Growth Rate (2013-2023)
10.4 Disease-Modifying Therapy Revenue Growth Rate (2013-2023)
11 Global Huntington’s Disease Treatment Market Segment by Application
11.1 Global Huntington’s Disease Treatment Revenue Market Share by Application (2013-2018)
11.2 Huntington’s Disease Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
12 Global Huntington’s Disease Treatment Market Size Forecast (2018-2023)
12.1 Global Huntington’s Disease Treatment Market Size Forecast (2018-2023)
12.2 Global Huntington’s Disease Treatment Market Forecast by Regions (2018-2023)
12.3 North America Huntington’s Disease Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Huntington’s Disease Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Huntington’s Disease Treatment Revenue Market Forecast (2018-2023)
12.6 South America Huntington’s Disease Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Huntington’s Disease Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Huntington’s Disease Treatment Picture
Table Product Specifications of Huntington’s Disease Treatment
Table Global Huntington’s Disease Treatment and Revenue (
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
